Clinical Trial Update: Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating sequential chemotherapy for patients with residual disease after surgery for advanced ovarian cancer (stages IIB–IV).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: SmithKline Beecham | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN